Bid to delay three-week AFT Pharmaceuticals trial declined

Bid to delay three-week AFT Pharmaceuticals trial declined
AFT Pharmaceuticals' managing director Hartley Atkinson is claiming PBL Solutions is taking against the NZX-listed company. (Image: Supplied)
Riley Kennedy
AFT Pharmaceuticals will face off against a former joint venture partner after the high court rejected a bid to delay the dispute's hearing until 2024.In the high court at Auckland, Justice Geoffrey Venning affirmed a three-week hearing between AFT and British Virgin Islands-based PBL Solutions will take place in October this year, bringing their two-year-old dispute to a head. PBL sought to have the case pushed out by 12 months, although the courts wouldn't have been able to hear it before 2024.While the judge rejected the applica...

More Markets

Air NZ's FY net profit slides in soft market
Markets

Air NZ's FY net profit slides in soft market

Air New Zealand has made a $126 million net profit after tax, down from $146m the year before.The airline stated that its 2025 financial year results reflected a sluggish domestic market, global engine maintenance challenges, and significant cost inflation.Earnings before tax wer...

Rakon power struggle ends: Witten to walk
Markets

Rakon power struggle ends: Witten to walk

In an exclusive statement, Brent Robinson reveals a new board will be in place in weeks.

The advice Ebos' new boss got from John Cullity
Markets

The advice Ebos' new boss got from John Cullity

Adam Hall says there are two trends which made Ebos attractive to him.

Govt capital-market reforms decisions due in months
Economy

Govt capital-market reforms decisions due in months

Finance industry insiders have expressed concern about the pace of progress.